Differential pulse polarographic assay procedure and in vitro biopharmaceutical properties of dipotassium clorazepate.
D014151:Anti-Anxiety Agents / Q000032:analysis*; D001702:Biopharmaceutics; D003009:Clorazepate Dipotassium / Q000032:analysis*; D004355:Drug Stability; D008722:Methods; D011048:Polarography
D014151:Anti-Anxiety Agents; D003009:Clorazepate Dipotassium